GlassScriptPhysician profile
David M Hasl
NPI 1710978424
$12,177.11
in general payments reported to CMS, 2019-2025
20 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $23.40 · 2021: $5,144 · 2022: $6,195 · 2023: $192 · 2024: $266 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,253.95 | 2019-2023 | Da Vinci Surgical System |
| Davol INC. | $133.08 | 2021 | |
| Genzyme Corporation | $123.87 | 2024 | |
| Becton, Dickinson and Company | $116.41 | 2019 | |
| Steris Corporation | $80.69 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $74.04 | 2021-2025 | Exparel, Iovera, Zilretta |
| Stryker Corporation | $70.14 | 2021 | |
| Baxter Healthcare | $50.97 | 2024-2025 | Tisseel |
| Boston Scientific Corporation | $36.74 | 2025 | General - Endochoice |
| Wound Management Technologies, INC | $33.98 | 2019 | |
| Merck Sharp & Dohme LLC | $31.21 | 2025 | Bridion |
| Ethicon US, LLC | $29.06 | 2024 | Echelon Endopath, Echelon; Endopath |
| Sanara Medtech INC. | $23.40 | 2020 | |
| Kerecis Limited | $21.84 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Endo Pharmaceuticals INC. | $21.29 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $20.91 | 2023 | Sutab |
| Tela Bio, INC. | $16.93 | 2021 | |
| Avanos Medical | $13.36 | 2022 | |
| Elucent Medical | $12.92 | 2024 | |
| Heron Therapeutics, INC. | $12.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hasl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.